NECIA GARRETT: Open Payments
NPI 1710342456 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 73 payments from 19 companies in 2025. Trend: 2023 $1,352 · 2024 $1,314 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $327 |
| Otsuka America Pharmaceutical, Inc. | 11 | $150 |
| PFIZER INC. | 5 | $78 |
| Novo Nordisk Inc | 5 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
| Amgen Inc. | 3 | $43 |
| Tris Pharma Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: REXULTI, UBRELVY, QULIPTA, CAPLYTA, ELIQUIS, Ozempic, VRAYLAR, MOUNJARO.
Industry payments across KY — which companies pay providers there.
